A detailed history of Westbourne Investment Advisors, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Westbourne Investment Advisors, Inc. holds 19,810 shares of PFE stock, worth $497,825. This represents 0.2% of its overall portfolio holdings.

Number of Shares
19,810
Previous 19,810 -0.0%
Holding current value
$497,825
Previous $554,000 3.43%
% of portfolio
0.2%
Previous 0.2%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

SELL
$25.89 - $29.73 $19,417 - $22,297
-750 Reduced 3.65%
19,810 $550,000
Q3 2023

Nov 06, 2023

SELL
$32.09 - $37.51 $24,067 - $28,132
-750 Reduced 3.52%
20,560 $682,000
Q1 2022

Jun 15, 2022

BUY
$45.75 - $56.69 $2,287 - $2,834
50 Added 0.24%
21,310 $1.1 Million
Q4 2021

Jan 24, 2022

BUY
$41.32 - $61.25 $340,890 - $505,312
8,250 Added 63.41%
21,260 $1.26 Million
Q2 2021

Aug 02, 2021

SELL
$35.91 - $40.68 $71,820 - $81,360
-2,000 Reduced 13.32%
13,010 $509,000
Q1 2021

Apr 27, 2021

SELL
$33.49 - $37.77 $13,396 - $15,108
-400 Reduced 2.6%
15,010 $544,000
Q3 2020

Nov 03, 2020

BUY
$31.75 - $37.25 $1,587 - $1,862
50 Added 0.33%
15,410 $566,000
Q2 2020

Jul 14, 2020

SELL
$30.12 - $36.54 $103,733 - $125,843
-3,444 Reduced 18.32%
15,360 $502,000
Q1 2020

Apr 21, 2020

SELL
$27.03 - $38.62 $29,733 - $42,482
-1,100 Reduced 5.53%
18,804 $614,000
Q4 2019

Jan 23, 2020

SELL
$32.92 - $37.36 $16,460 - $18,680
-500 Reduced 2.45%
19,904 $780,000
Q3 2019

Oct 22, 2019

BUY
$32.49 - $42.13 $18,194 - $23,592
560 Added 2.82%
20,404 $733,000
Q2 2019

Jul 22, 2019

SELL
$36.98 - $41.52 $207,087 - $232,512
-5,600 Reduced 22.01%
19,844 $860,000
Q1 2019

Apr 15, 2019

SELL
$37.5 - $41.2 $45,000 - $49,440
-1,200 Reduced 4.5%
25,444 $1.08 Million
Q4 2018

Jan 18, 2019

BUY
$38.47 - $43.86 $115,410 - $131,580
3,000 Added 12.69%
26,644 $1.16 Million
Q3 2018

Oct 18, 2018

SELL
$34.47 - $41.81 $6,894 - $8,362
-200 Reduced 0.84%
23,644 $1.04 Million
Q2 2018

Aug 07, 2018

SELL
$32.98 - $35.16 $26,383 - $28,127
-800 Reduced 3.25%
23,844 $865,000
Q1 2018

May 08, 2018

SELL
$31.91 - $37.02 $92,539 - $107,358
-2,900 Reduced 10.53%
24,644 $875,000
Q4 2017

Jan 31, 2018

BUY
$33.26 - $35.29 $19,956 - $21,174
600 Added 2.23%
27,544 $998,000
Q3 2017

Oct 23, 2017

BUY
$31.0 - $34.15 $835,264 - $920,137
26,944
26,944 $962,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $141B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Westbourne Investment Advisors, Inc. Portfolio

Follow Westbourne Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westbourne Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Westbourne Investment Advisors, Inc. with notifications on news.